Is Generic Ciprofloxacin as Good as Cipro?All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating.
An "AB" rating (or "AP" rating for injectable products) means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic versions of Cipro currently available have an "AB" or "AP" rating, meaning they should be equivalent to Cipro.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.
When Will Generic Cipro Oral Suspension Be Available?
A patent for Cipro oral suspension already expired in July 2013. However, a generic version is not yet available. This strongly suggests that the next patent (set to expire in June 2015) is still providing significant protection against generic competition. This is the earliest predictable date that a generic version could become available.
However, there are other circumstances that could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Cipro uses. Once the drug goes off-patent, there may be several companies that manufacture a generic Cipro oral suspension.